Prophylaxis of graft rejection

Transplant rejection occurs when transplanted tissue is rejected by the immune system, which destroys the transplanted tissue. Transplant rejection can be diminished by determining the molecular similarity between donor and recipient and by using immunosuppressant drugs after transplant. The prevention of this condition conducts to the higher success of the transplant procedure.

Showing the single result

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
1
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price from
CD80
,
CD86
Fusion protein
Nulojix®
25 mg/mL
5 mg
-80°C
01/2025
214,00 
view product
Max: 10
Min: 2
Step: 1

Not looking for Prophylaxis of graft rejection?

Search our therapeutic molecules product database